Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis
Clinical trial NCT00367965 · COMPLETED
Trial details
- NCT number
- NCT00367965
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2004-11-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.